• Explore /
  • Poster
  • / A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer.

A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer.

Abstract Video & Slides Poster

Authors

null

Paul Bernard Romesser

Memorial Sloan Kettering Cancer Center, New York, NY

Paul Bernard Romesser , Emma B. Holliday , Tony Philip , Rocio Garcia-Carbonero , Jaume Capdevila , Richard Tuli , Barbara Sarholz , Mirjam Kuipers , Almudena Rodriguez , Ivan Diaz-Padilla , Eric David Miller

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03770689

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr TPS144)

DOI

10.1200/JCO.2021.39.3_suppl.TPS144

Abstract #

TPS144

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Paul Bernard Romesser

First Author: Brian G. Czito

First Author: Brian G. Czito

First Author: Michael Michael